Newsroom

Company news, product launches and press coverage from EClinCloud.

Article imageNews1 min read520 International Clinical Trials Day | Lighting Hope with Love and TechnologyHonoring every clinical trial participant. ↓↓↓ Click below to watch the video. About EClinCloud: EClinCloud is a leading AI company in the clinical research industry. Powered by AI, it builds an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to establish efficient, accurate digital solutions. Leveraging AI predictive models and an intelligent data platform, it dynamically evaluates and helps improve drug clinical trial success rates.Archived article cover: Campus Recruitment Is Here | EClinCloud AI Main Quest Released—Players, Assemble!News1 min readCampus Recruitment Is Here | EClinCloud AI Main Quest Released—Players, Assemble!Campus Recruitment Is Here | EClinCloud AI Main Quest Released—Players, Assemble! 2025 · Campus RecruitmentCover image for archived article: EClinCloud invites you to join us at the 2025 DIA China Annual Meeting to explore the transformative potential of AI in clinical researchNews1 min readEClinCloud Invites You to the 2025 DIA China Annual Meeting to Explore the Transformative Potential of AI in Clinical ResearchFrom May 22 to 25, EClinCloud will appear at the 2025 DIA China Annual Meeting & Exhibition.Article imageNews1 min readInternational Workers' Day | Relentless Effort, Honoring Every CommitmentEClinCloud published "International Workers' Day | Relentless Effort, Honoring Every Commitment" on 2025-05-01. Full text and accompanying images are included in this article.Presentation Recap | Data-Driven Enablement: New Practices in Patient-Centered Risk Prevention and Control (archived article cover)News2 min readPresentation Recap | Data-Driven Enablement: New Practices in Patient-Centered Risk Prevention and ControlRecently, at the DIA RBQM Symposium, Dr. Qin Long, Founder & CEO of EClinCloud, was invited to deliver a keynote speech titled "Data-Driven RBQM: How eCOA + EDC Enhances Patient-Centered Risk Prevention and Control," sharing how cutting-edge technology reshapes clinical trial risk management models and offering profound insights to the industry.Archived article cover: Good news! EClinCloud wins First Prize at the Inaugural AI-Empowered Industry CompetitionNews1 min readGood News! EClinCloud Wins First Prize at the Inaugural AI-Empowered Industry CompetitionAt the recently concluded inaugural "AI Ningbo" AI-Empowered Industry Competition, EClinCloud stood out from 1190 projects across more than 20 countries and regions worldwide, winning the competition's highest award, First Prize (with no Grand Prize awarded), and receiving associated funding support. This competition, which tested core AI technical capabilities, fully validated EClinCloud's technical foundation and implementation capabilities in "AI + clinical trials" and demonstrated its strong product capabilities and potential for industry leadership.640 (1).jpgNews3 min readDIA Workshop Invitation | EClinCloud Founder Dr. Qin Long to Present on Data-Driven RBQMEClinCloud published "DIA Workshop Invitation | EClinCloud Founder Dr. Qin Long to Present on Data-Driven RBQM" on 2025-04-14. See this article for the full text and images.Article imageNews1 min readToday Is Qingming Festival | Clear Breeze, Bright Scenery, Lush GreenAbout EClinCloud: EClinCloud is a leading AI company in the clinical research industry. Driven by AI, it builds an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, along with scale management, linguistic validation, rater training, and data quality analysis services to deliver efficient, precise digital solutions. Leveraging AI predictive models and an intelligent data platform, EClinCloud dynamically evaluates and helps improve drug clinical trial success rates, helping shorten drug/device R&D cycles to benefit patients.Archived article cover: EClinCloud and R&G PharmaStudies deepen strategic partnership to advance intelligent clinical trial managementNews3 min readEClinCloud and R&G PharmaStudies Deepen Strategic Partnership to Advance Intelligent Clinical Trial ManagementEClinCloud and R&G PharmaStudies jointly announced that they will deepen their strategic partnership. Building on a solid foundation of collaboration in CTMS (clinical trial management system) and eTMF (electronic trial master file), the two parties will continue working together to advance the further application of solutions including EDC (electronic data capture), eCOA (electronic clinical outcome assessment), and scale copyright management.Ark Biosciences smoothly completes the Aizhida™ Phase III clinical study, supported throughout by EClinCloud eCOA! Archived article coverNews4 min readArk Biosciences Successfully Completes Phase III Clinical Study of Aizhida™, Supported Throughout by EClinCloud eCOAOn March 24, Shanghai Ark Biopharmaceutical Technology Co., Ltd. ("Ark Biosciences") announced that the Phase III clinical study of its new drug Aizhida™ (AK0901) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adults has been successfully completed. This milestone marks a solid step forward for Ark Biosciences in drug development for pediatric psychiatric disorders and is expected to provide new treatment options and a better treatment experience for pediatric and adult patients with ADHD in China.CMAC Recap | Charting Digital Practice in Clinical Research with AI (archived article cover)News2 min readCMAC Recap | Charting Digital Clinical Research Practices with AIFrom March 18 to 20, the 2025 CMAC Annual Conference was successfully held in Suzhou, where EClinCloud presented its AI-driven digital clinical research solutions.EClinCloud and Hongfeng Investment financing announcementNews2 min readEClinCloud completes new financing round to accelerate clinical-research AIHongfeng Investment led a new financing round for EClinCloud to advance AI development, global delivery, and digital infrastructure for drug and device trials.